Tofacitinib for new-onset adult patients with anti-melanoma differentiation-associated 5 gene antibody positive dermatomyositis

2017 European League Against Rheumatism/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups

Ingrid E. Lundberg, Anna Tjärnlund, Matteo Bottai et al. · Annals of the Rheumatic Diseases · 2017 · 1.5K citations · Full text

Medicine, Dermatology, Pediatrics +13

Multicenter Prospective Study of the Efficacy and Safety of Combined Immunosuppressive Therapy With High‐Dose Glucocorticoid, Tacrolimus, and Cyclophosphamide in Interstitial Lung Diseases Accompanied by Anti–Melanoma Differentiation–Associated Gene 5–Positive Dermatomyositis

Hideaki Tsuji, Ran Nakashima, Yuji Hosono et al. · Arthritis & Rheumatology · 2019 · 361 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Anti-MDA5 antibody, ferritin and IL-18 are useful for the evaluation of response to treatment in interstitial lung disease with anti-MDA5 antibody-positive dermatomyositis

Takahisa Gono, Shoichiro Sato, Yasushi Kawaguchi et al. · Lara D. Veeken · 2012 · 337 citations · Full text

Medicine, Immunology, Internal Medicine +14

Tofacitinib for refractory interstitial lung diseases in anti-melanoma differentiation-associated 5 gene antibody-positive dermatomyositis

Kazuhiro Kurasawa, Satoko Arai, Y. Namiki et al. · Lara D. Veeken · 2018 · 297 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Different phenotypes in dermatomyositis associated with anti-MDA5 antibody

Yves Allenbach, Y. Uzunhan, S. Toquet et al. · Neurology · 2020 · 251 citations · Full text

Life Sciences, Dermatology, Immunology +17